title: Reply to C.G. Azzoli et al and C. Chouaid et al.
authors.affiliation: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
authors.forename: Ronan J
authors.initials: RJ
authors.lastname: Kelly
authors.affiliation: Virginia Commonwealth University, Richmond, VA.
authors.forename: Bruce E
authors.initials: BE
authors.lastname: Hillner
authors.affiliation: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD tsmit136@jhmi.edu.
authors.forename: Thomas
authors.initials: T
authors.lastname: Smith
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D007150:Immunohistochemistry / Q000191:economics*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000191:economics*; D015514:Oncogene Proteins, Fusion / Q000032:analysis*; D011720:Pyrazoles / Q000191:economics*; D011725:Pyridines / Q000191:economics*
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D015514:Oncogene Proteins, Fusion; D011720:Pyrazoles; D011725:Pyridines